Brief: Qualigen Therapeutics Gains Extension To Regain Compliance With Minimum Bid Price Requirement
02/09/2022 12:23
Sept 2 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS- ON SEPT 1 GOT LETTER FROM NASDAQ
THAT CO
IS GRANTED EXTENSION TO FEB 27, 2023 TO REGAIN COMPLIANCE WITH
MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise